Matakina to Expand Objective Breast Density Measurement to More Mammography Systems with Launch of Latest Version of Volpara Imaging Software at RSNA
New Version Processes Fuji, Philips, IMS Giotto and Medi-Future Studies as well as
Mammography Studies Acquired by Siemens, Hologic and GE Digital Systems;
WELLINGTON, New Zealand, – November 15, 2012
– (Virtual Press Office
) – Matakina International today announced the launch of Volpara Imaging Software 1.5.7 which expands the number of digital mammography systems on which the software can be used to offer objective breast density measurements to include Fuji, Philips, IMS Giotto and Medi-Future in addition to processing mammography studies acquired on GE, Hologic, Siemens digital mammography systems. The company will showcase the new software package at the 98th Annual Meeting of the Radiology Society of North America, November 25-30, 2012. (RSNA Booth 6629 – South Hall).
“This is a remarkable validation of the robustness of the technology that it has proved to work so well on all the various digital mammography systems,” said Professor Martin Yaffe, Professor of Biomedical Physics at the University of Toronto and one of the founders of Matakina.
Cleared by the FDA, HealthCanada, the TGA and CE-marked, Volpara is in use at sites across the globe helping radiologists assess breast density more objectively and helping them better consider who might benefit from additional screening. Those installations include major Hologic sites such as Reading Hospital and Medical Center in West Reading, Penn., GE sites such as Boca Raton Radiology in Boca Raton, Fla., Siemens sites such as El Camino Hospital, in Mountain View, Calif., and soon Fuji and Philips.
“Our Center is committed to informing our patients of their breast density at the time of their screening mammography. With eight breast radiologists we believe it mandatory that we standardize the quantification of breast density. We have found Volpara to decrease inter and intraobserver variation in breast density determination thereby optimizing the care of our patients,” said Kathy Schilling, M.D., radiologist at Boca Raton, Florida who has GE mammography systems.
Volpara is a reliable tool which automatically generates objective, measurement of volumetric breast density values under the Volpara Density Grade (VDG®) – a refined grading system which correlates with the American College of Radiology BIRADS Density Grading Classifications. Volpara is FDA cleared for all digital mammography units, and integration with other digital mammography systems, CAD systems and mammography reporting system are also underway.
“Matakina is committed to developing the world’s best breast imaging assessment software. We have a fantastic team of scientists with more than 80 years of experience in breast density and we will continue to innovate and develop our products to make them work better, on more mammography machines, and to bring new, potentially life-saving ideas through to market,” said Ralph Highnam, CEO of Matakina International.
Founded to enable radiologists to give women the most accurate information possible regarding their breast health, Matakina International, Limited is the wholly owned sales and marketing arm of Matakina Technology Limited of New Zealand. Volpara’s founders and Board of Directors includes John Hood, PhD, former Vice Chancellor of the University of Oxford, UK; Ralph Highnam, PhD, former CEO of Mirada Solutions, one of the University of Oxford’s most successful spin-outs of recent times and co-author of the seminal book Mammographic Image Analysis; and Professor Sir Michael Brady, a serial entrepreneur who recently retired from the University of Oxford where he was Professor of Information Technology for 25 years.
# # #
Chris K. Joseph